https://www.axios.com/coronavirus-masks-cdc-guidance-52aaae87-7ea5-4a3b-8ebf-66e3f542ef77.html?utm_source=twitter&utm_medium=social&utm_campaign=editorial&utm_content=health-cdc
Morgan Stanley Maintains Underweight on Visteon, Raises Price Target to $75
Morgan Stanley maintains Visteon (NASDAQ:VC) with a Underweight and raises the price target from $71 to $75.